CORD-19:038354e8830fe01feb621a12e8a8c467a15b6354 / 118204-118488
Annnotations
CORD-19-Sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
TextSentencer_T718 | 0-284 | Sentence | denotes | Despite a concern that pre-existing antibodies against HA would block virosome-mediated CTL priming, mice with a high pre-existing antibody titer against virosomal HA developed a strong ovalbumin-specific CTL response after subsequent immunization with ovalbumin-containing virosomes. |
T76197 | 0-284 | Sentence | denotes | Despite a concern that pre-existing antibodies against HA would block virosome-mediated CTL priming, mice with a high pre-existing antibody titer against virosomal HA developed a strong ovalbumin-specific CTL response after subsequent immunization with ovalbumin-containing virosomes. |
Epistemic_Statements
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T289 | 0-284 | Epistemic_statement | denotes | Despite a concern that pre-existing antibodies against HA would block virosome-mediated CTL priming, mice with a high pre-existing antibody titer against virosomal HA developed a strong ovalbumin-specific CTL response after subsequent immunization with ovalbumin-containing virosomes. |
CORD-19_Custom_license_subset
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T123 | 0-284 | Sentence | denotes | Despite a concern that pre-existing antibodies against HA would block virosome-mediated CTL priming, mice with a high pre-existing antibody titer against virosomal HA developed a strong ovalbumin-specific CTL response after subsequent immunization with ovalbumin-containing virosomes. |